The Food and Drug Administration (FDA) is withdrawing approval of 54 abbreviated new drug applications (ANDAs) from two applicants. The holders of the applications notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Document
Watson Laboratories, Inc., and Barr Laboratories, Inc., Subsidiaries of Teva Pharmaceuticals USA, Inc.; Withdrawal of Approval of 54 Abbreviated New Drug Applications
The Food and Drug Administration (FDA) is withdrawing approval of 54 abbreviated new drug applications (ANDAs) from two applicants. The holders of the applications notified the ...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 49214
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Watson Laboratories, Inc., and Barr Laboratories, Inc., Subsidiaries of Teva Pharmaceuticals USA, Inc.; Withdrawal of Approval of 54 Abbreviated New Drug Applications,” thefederalregister.org (October 24, 2017), https://thefederalregister.org/documents/2017-23046/watson-laboratories-inc-and-barr-laboratories-inc-subsidiaries-of-teva-pharmaceuticals-usa-inc-withdrawal-of-approval-of.